Royalty Pharma

RPRXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$32.643 B

$56.77 -0.86%

Close of 7 Aug 2026

Revenue

$2.38B

#1049 by revenue

Earnings

$770.9M

#473 by earnings

Shares outstanding

557,352,000

Latest filing cover page

P/E ratio

42.3

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#16Teva Pharmaceutical IndustriesTEVA$41.2B
#17BeOne MedicinesONC$39.6B
#18Royalty PharmaRPRX$32.6B
#19ZoetisZTS$30.5B
#20Alnylam PharmaceuticalsALNY$29.3B

Where these numbers come from

Share counts and financials for Royalty Pharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.